Literature DB >> 1411836

Temporal trends in gonococcal antibiotic resistance in Baltimore.

C A Reichart1, T Neumann, P Foreman, J M Zenilman, E W Hook.   

Abstract

Each month from August 1986 through July 1990, clinical and laboratory data were evaluated for the first 25 urethral isolates of Neisseria gonorrhoeae from men attending a Baltimore sexually transmitted disease (STD) clinic as part of an effort to understand factors that contribute to changes in gonococcal antimicrobial susceptibility. During the 48-month study period, 1193 gonococcal isolates were evaluated; the proportion of penicillinase-producing N. gonorrhoeae (PPNG) isolates steadily increased, the prevalence of tetracycline-resistant N. gonorrhoeae (TRNG) remained relatively stable, and chromosomally mediated penicillin resistance increased steadily during the first 5 6-month intervals, then decreased, only to increase again during the final 2 6-month intervals. Changes in antibiotic treatment regimens for gonorrhea were associated with changes in the prevalence of chromosomally mediated penicillin resistance. In a supplementary study to characterize patterns of antibiotic use among men and women attending the STD clinics, 9% of patients reported antibiotic use in the 2 weeks prior to clinic visit. Antibiotics were taken prior to clinic attendance by 65% of patients reporting antibiotic use, because of concerns regarding possible STD or STD exposure. These patients were significantly less likely to be culture positive for N. gonorrhoeae when compared with patients who did not report antibiotic use. Temporal trends in N. gonorrhoeae antibiotic resistance appear to be influenced by many factors, including treatment regimens and self medication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1411836     DOI: 10.1097/00007435-199207000-00006

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  8 in total

1.  Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme.

Authors:  J R Schwebke; M E Zajackowski
Journal:  Genitourin Med       Date:  1996-04

2.  Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.

Authors:  M J van de Laar; Y T van Duynhoven; M Dessens; M van Santen; B van Klingeren
Journal:  Genitourin Med       Date:  1997-12

3.  Temporal trends in gonococcal population genetics in a high prevalence urban community.

Authors:  Marcos Pérez-Losada; Keith A Crandall; Jonathan Zenilman; Raphael P Viscidi
Journal:  Infect Genet Evol       Date:  2006-12-01       Impact factor: 3.342

4.  Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.

Authors:  E W Hook; G B Pinson; C J Blalock; R B Johnson
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.

Authors:  E W Hook; R B Jones; D H Martin; G A Bolan; T F Mroczkowski; T M Neumann; J J Haag; R Echols
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

6.  Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.

Authors:  J M Zenilman; T Neumann; M Patton; C Reichart
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

7.  Determinants of penicillinase producing Neisseria gonorrhoeae infections in heterosexuals in Amsterdam.

Authors:  M Prins; P J Bindels; R A Coutinho; C J Henquet; G J van Doornum; J A van den Hoek
Journal:  Genitourin Med       Date:  1994-08

8.  Intrapartum management relating to the risk of perinatal transmission of group B streptococcus.

Authors:  E M Levine; C M Strom; V Ghai; J J Barton
Journal:  Infect Dis Obstet Gynecol       Date:  1998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.